Stage 1 Progress

Future product generations will be designed for:

• Large-scale screening
• Use in ICU
• Neonatal, small children, and infants
• Multimodal functionality

World’s first dedicated lung function scanner:

• Will allow for a faster scanning process
• Will be extremely low-dose
• Enables a patient to be scanned in an upright position
• Will be straightforward and easy to use

How is it also inadequate for children, elderly & the very sick?

The University of Adelaide is a world-class higher-education research institution well-known and highly respected for its leadership in advanced collaborative research and innovation. The university’s respiratory physiologists have teamed up with SAHMRI and are currently conducting preclinical testing, as well as the testing of scanner prototypes to provide feedback to design engineers.

Telethon Kids Institute is a research organization committed to bringing together community, researchers, practitioners, policy makers and funders to improve the health and wellbeing of children through excellence in research. With international support from Children’s Hospital LA and the University of Alabama at Birmingham, Telethon’s medical researchers will lead clinical trials to validate the ALHI scanners to markets and regulators.

The South Australian Health & Medical Research Institute (SAHMRI) is an independent health and medical research facility, providing ALHI with high quality disease and treatment research capabilities. Respiratory physiologists from SAHMRI are currently teamed up with The University of Adelaide to conduct preclinical testing across a range of models, take charge in testing prototypes, providing feedback to engineers and physicists for continuous improvement.

The largest university in Australia, Monash is known for its world-class science and technology research programs. Physicists from Monash are driving the proof of concept studies aimed at the drastic reduction of X-ray radiation dose. In addition, respiratory physiologists from Monash are using prototype scanners to gain new insights into lung diseases and their treatments while data scientists direct cybersecurity and Artificial Intelligence (AI) layers of the project.

Micro-X is a national leader in the manufacturing of innovative, award-winning X-ray scanners and has a track record of design excellence and intellectual property in imaging systems for medical and security applications. Engineers from Micro-X are taking the central role in leading the design effort for prototyping and manufacturing of the ALHI scanners to ensure successful translation of the research into a high-impact commercial product.

4Dx is an Australian-based medtech company responsible for the development of XV Technology™, a revolutionary new analytical platform that images the lungs by uniquely measuring the motion of the lung tissue. 4Dx founder and CEO, Prof Andreas Fouras, and 4Dx engineers have taken the technical lead in Stage One by providing the algorithm development, plus scanner hardware and software design. With staff positioned in Adelaide, 4Dx engineers are currently undertaking prototype development and testing.